share_log

HC Wainwright & Co. Maintains Buy on KemPharm, Lowers Price Target to $10

HC Wainwright & Co. Maintains Buy on KemPharm, Lowers Price Target to $10

HC Wainwright & Co.維持KempHarm的買入,將目標價下調至10美元
Benzinga Real-time News ·  2022/08/17 06:40

HC Wainwright & Co. analyst Oren Livnat maintains KemPharm (NASDAQ:KMPH) with a Buy and lowers the price target from $11 to $10.

HC Wainwright & Co. 分析師奧倫·利夫納特維持KempHarm(納斯達克股票代碼:KMPH)的買入,並將目標股價從11美元下調至10美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論